Literature DB >> 18596438

Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus.

Matthew J McGirt1, Graeme Woodworth, Alexander L Coon, George Thomas, Michael A Williams, Daniele Rigamonti.   

Abstract

OBJECTIVE: The response to shunt surgery for idiopathic normal-pressure hydrocephalus (INPH) is variable because INPH is difficult to distinguish from other conditions causing the same symptoms. To date, no clinical picture or diagnostic test can distinguish INPH or predict response to cerebrospinal fluid (CSF) shunt surgery. We reviewed our 10-year experience with INPH to characterize long-term outcome and to identify independent predictors of outcome after shunt surgery.
METHODS: Patients were classified as having INPH only if they had: 1) ventriculomegaly, 2) two or more INPH clinical features, 3) no risk factor for secondary normal-pressure hydrocephalus, 4) A- or B-waves on CSF pressure monitoring, and 5) clinical improvement during a 3-day CSF drainage trial via a spinal catheter. Independent predictors of outcome were assessed via a multivariate proportional hazards regression analysis.
RESULTS: One hundred thirty-two patients underwent 179 shunt surgeries. Forty-four (33%), 79 (60%), and 99 (75%) patients demonstrated objective improvement 3, 6, and 24 months after shunt surgery, respectively. Gait improved first in 88 (93%) patients. Dementia and urinary incontinence were twofold less likely to improve. Radiological evidence of corpus callosum distension, gait impairment as the primary symptom, and shorter duration of INPH symptoms predicted improvement. Duration of symptoms and gait as the primary symptom were independent predictors by multivariate analysis.
CONCLUSION: INPH can be diagnosed accurately with CSF pressure monitoring and CSF drainage via a spinal catheter. CSF shunting is safe and effective for INPH with a long-term shunt response rate of 75%. Independent predictors of improvement are the presence of gait impairment as the dominant symptom and shorter duration of symptoms.

Entities:  

Year:  2008        PMID: 18596438     DOI: 10.1227/01.neu.0000316271.90090.b9

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  16 in total

1.  Longitudinal Metabolite Profiling of Cerebrospinal Fluid in Normal Pressure Hydrocephalus Links Brain Metabolism with Exercise-Induced VEGF Production and Clinical Outcome.

Authors:  He Huang; Jun Yang; Mark Luciano; Leah P Shriver
Journal:  Neurochem Res       Date:  2016-04-15       Impact factor: 3.996

2.  Normal Pressure Hydrocephalus as Cause of Urinary Incontinence - A Shunt for Incontinence.

Authors:  R Rendtorff; A Novak; R Tunn
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-12       Impact factor: 2.915

3.  Long term follow-up of shunted idiopathic normal pressure hydrocephalus patients: a single center experience.

Authors:  Matheus Fernandes de Oliveira; A A Boa Sorte; D L Emerenciano; J M Rotta; G A S Mendes; F C G Pinto
Journal:  Acta Neurol Belg       Date:  2020-11-02       Impact factor: 2.396

4.  Idiopathic normal pressure hydrocephalus: postoperative patient perspective and quality of life.

Authors:  Francesco Belotti; Marta Pertichetti; Andrea Muratori; Karol Migliorati; Pier Paolo Panciani; Riccardo Draghi; Umberto Godano; Ignazio Borghesi; Marco Maria Fontanella
Journal:  Acta Neurochir (Wien)       Date:  2022-07-02       Impact factor: 2.216

5.  Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus.

Authors:  Madoka Nakajima; Masakazu Miyajima; Ikuko Ogino; Maki Watanabe; Haruko Miyata; Kostadin L Karagiozov; Hajime Arai; Yoshiaki Hagiwara; Tatsuya Segawa; Kyoko Kobayashi; Yasuhiro Hashimoto
Journal:  Acta Neurochir (Wien)       Date:  2011-02-19       Impact factor: 2.216

6.  Revisiting hydrocephalus as a model to study brain resilience.

Authors:  Matheus Fernandes de Oliveira; Fernando Campos Gomes Pinto; Koshiro Nishikuni; Ricardo Vieira Botelho; Alessandra Moura Lima; José Marcus Rotta
Journal:  Front Hum Neurosci       Date:  2012-01-06       Impact factor: 3.169

7.  Nationwide hospital-based survey of idiopathic normal pressure hydrocephalus in Japan: Epidemiological and clinical characteristics.

Authors:  Nagato Kuriyama; Masakazu Miyajima; Madoka Nakajima; Michiko Kurosawa; Wakaba Fukushima; Yoshiyuki Watanabe; Etsuko Ozaki; Yoshio Hirota; Akiko Tamakoshi; Etsuro Mori; Takeo Kato; Takahiko Tokuda; Akinori Urae; Hajime Arai
Journal:  Brain Behav       Date:  2017-01-27       Impact factor: 2.708

8.  Long-Term Prognosis of Cognitive Function in Patients With Idiopathic Normal Pressure Hydrocephalus After Shunt Surgery.

Authors:  Akihiro Kambara; Yoshinaga Kajimoto; Ryokichi Yagi; Naokado Ikeda; Motomasa Furuse; Naosuke Nonoguchi; Shinji Kawabata; Toshihiko Kuroiwa; Kenji Kuroda; Shohei Tsuji; Ryuichi Saura; Masahiko Wanibuchi
Journal:  Front Aging Neurosci       Date:  2021-01-20       Impact factor: 5.750

9.  Deletions in CWH43 cause idiopathic normal pressure hydrocephalus.

Authors:  Hong Wei Yang; Semin Lee; Dejun Yang; Huijun Dai; Yan Zhang; Lei Han; Sijun Zhao; Shuo Zhang; Yan Ma; Marciana F Johnson; Anna K Rattray; Tatyana A Johnson; George Wang; Shaokuan Zheng; Rona S Carroll; Peter J Park; Mark D Johnson
Journal:  EMBO Mol Med       Date:  2021-01-18       Impact factor: 12.137

10.  Asymmetric hearing loss and chronic dizziness in a patient with idiopathic normal pressure hydrocephalus.

Authors:  Theodoros Varakliotis; Federico Maspes; Vittoria Di Rubbo; Sara Cisternino; Maria Lauriello; Elisa Vitti; Alberto Eibenstein
Journal:  Audiol Res       Date:  2018-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.